Pacira Pharmaceuticals Inc (PCRX.OQ)
PCRX.OQ on NASDAQ Stock Exchange Global Select Market
47.54USD
2:29am IST
47.54USD
2:29am IST
Change (% chg)
$-0.33 (-0.69%)
$-0.33 (-0.69%)
Prev Close
$47.87
$47.87
Open
$48.03
$48.03
Day's High
$48.46
$48.46
Day's Low
$46.28
$46.28
Volume
185,151
185,151
Avg. Vol
171,445
171,445
52-wk High
$54.92
$54.92
52-wk Low
$26.98
$26.98
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | 0.26 | December | 15 Nov 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 2 | 2 |
| (2) OUTPERFORM | 5 | 5 | 6 | 7 |
| (3) HOLD | 8 | 8 | 8 | 8 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 2 | 2 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.71 | 2.71 | 2.53 | 2.50 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 17 | 92.05 | 95.58 | 86.61 | 91.95 |
| Quarter Ending Mar-19 | 6 | 86.32 | 89.19 | 80.60 | 103.00 |
| Year Ending Dec-18 | 17 | 332.77 | 337.74 | 328.29 | 332.10 |
| Year Ending Dec-19 | 17 | 383.23 | 414.81 | 339.89 | 400.74 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 16 | 0.26 | 0.43 | 0.04 | 0.28 |
| Quarter Ending Mar-19 | 3 | 0.27 | 0.30 | 0.23 | -- |
| Year Ending Dec-18 | 15 | 0.83 | 1.00 | 0.60 | 0.74 |
| Year Ending Dec-19 | 15 | 1.40 | 1.93 | -0.30 | 1.83 |
| LT Growth Rate (%) | 1 | 78.00 | 78.00 | 78.00 | 18.30 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Sep-18 | 80.18 | 83.45 | 3.26 | 4.07 |
| Quarter Ending Jun-18 | 79.13 | 81.11 | 1.98 | 2.50 |
| Quarter Ending Mar-18 | 73.83 | 74.61 | 0.77 | 1.05 |
| Quarter Ending Dec-17 | 79.32 | 79.08 | 0.24 | 0.31 |
| Quarter Ending Sep-17 | 69.65 | 67.33 | 2.31 | 3.32 |
| Earnings (per share) | ||||
| Quarter Ending Sep-18 | 0.08 | 0.31 | 0.23 | 284.14 |
| Quarter Ending Jun-18 | 0.07 | 0.24 | 0.17 | 226.53 |
| Quarter Ending Mar-18 | 0.02 | 0.02 | 0.00 | 16.32 |
| Quarter Ending Dec-17 | 0.10 | 0.38 | 0.28 | 297.49 |
| Quarter Ending Sep-17 | -0.06 | 0.11 | 0.17 | -298.92 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 92.05 | 92.05 | 89.42 | 89.33 | 91.95 |
| Quarter Ending Mar-19 | 86.32 | 86.32 | 84.99 | 83.70 | 103.00 |
| Year Ending Dec-18 | 332.77 | 332.77 | 327.10 | 327.02 | 332.10 |
| Year Ending Dec-19 | 383.23 | 383.23 | 377.87 | 375.85 | 400.74 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 0.26 | 0.26 | 0.19 | 0.20 | 0.28 |
| Quarter Ending Mar-19 | 0.27 | 0.27 | 0.26 | 0.20 | -- |
| Year Ending Dec-18 | 0.83 | 0.83 | 0.55 | 0.55 | 0.74 |
| Year Ending Dec-19 | 1.40 | 1.40 | 1.25 | 1.23 | 1.83 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Dec-18 | 0 | 0 | 13 | 2 |
| Quarter Ending Mar-19 | 0 | 0 | 4 | 0 |
| Year Ending Dec-18 | 0 | 0 | 16 | 0 |
| Year Ending Dec-19 | 0 | 0 | 13 | 2 |
| Earnings | ||||
| Quarter Ending Dec-18 | 0 | 0 | 12 | 2 |
| Quarter Ending Mar-19 | 0 | 0 | 1 | 1 |
| Year Ending Dec-18 | 0 | 0 | 13 | 0 |
| Year Ending Dec-19 | 0 | 0 | 12 | 2 |
Earnings vs. 
Estimates